Emerald Health Pharmaceuticals Provides Phase 2 Systemic Sclerosis Clinical Trial Update,

… class of medicines to treat diseases with unmet medical needs, continues to advance its Phase 2a clinical study of EHP-101, an oral formulation of a …, … class of medicines to treat diseases with unmet medical needs, continues to advance its Phase 2a clinical study of EHP-101, an oral formulation of a …, Read More

Scroll to Top